Companies researching CAR-T Cell Therapy
CAR‑T cell therapy engineers a patient's T cells to express chimeric antigen receptors, enabling them to identify and eliminate cancer cells, and is often classified as a cell‑based gene therapy.
505
companies
List of companies that research CAR-T Cell Therapy
This is sourced from job postings — companies only hire for what they actively use or plan to adopt · how we source this →
| Company | Country | Industry | Employees | Revenue | Technologies |
|---|---|---|---|---|---|
United States | Hospitals and Health Care | 138k | $94B | CAR-T Cell Therapy | |
United States | Higher Education | 18k | $5.1B | CAR-T Cell Therapy | |
United States | Pharmaceutical Manufacturing | 39k | $46B | CAR-T Cell Therapy | |
United Kingdom | Hospitals and Health Care | 193k | $105B | CAR-T Cell Therapy | |
United States | Biotechnology Research | 2.5k | $90M | CAR-T Cell Therapy | |
United States | Biotechnology Research | 4k | $45M | CAR-T Cell Therapy | |
United States | Hospitals and Health Care | 21k | $3.8B | CAR-T Cell Therapy | |
United States | Hospitals and Health Care | 12k | $2.4B | CAR-T Cell Therapy | |
United Kingdom | Pharmaceutical Manufacturing | 80k | CAR-T Cell Therapy | ||
United States | Biotechnology Research | 15k | $27B | CAR-T Cell Therapy |
Showing top companies out of 505 that research CAR-T Cell Therapy. Get the full list on TheirStack.
Frequently asked questions









